The literature review is suggestive of good efficacy of Linezolid (Oxazolinedione derivative) against gram positive bacteria only. However it is deficient regarding its susceptibility in various clinical isolates. Therefore, the current study was planned to identify the susceptibility pattern of Linezolid in various isolates. Total 748(n) specimens were included in this study.
Introduction
The Linezolid belongs to a group of Oxazolidinone group of antibiotics. In the year 2000, it was licensed by FDA (Food and Drug Administration) for the treatment of severe infections like
MRSA (Methicillin resistant Staphylococcus aureus) infections.
This is considered as a most common cause of complicated nosocomial infection having high morbidity rate. There are many latest studies available showing the efficacy of linezolid for the successful management of complicated gram positive infections like MRSA. However, the studies on its efficacy for gram negative infections are deficient. Therefore, the current study was planned to assess the susceptibility pattern of linezolid for both gram positive and gram negative isolates in our setup.
Materials and Methods
The current study was conducted at Pathology department of Al For ethical considerations, an informed consent was taken from all the patients prior study proceedings. Convenient sampling technique was adopted for the study proceedings. Total 748 specimens (indoor and outdoor) received for culture and sensitivity in microbiology section, were included in the study.
While the samples of non-willing patients were excluded from the study.
The recommended protocols for microbiological sample processing and CLSI -2014 (clinical and laboratory standard institute) guidelines were followed. The duration of sample processing for urine, HVS (high vaginal swabs), pus, stool, and sputum were 03 days. While for Blood cultures it was 07 days.
Blood agar, Macconkey's agar and CLED (cysteine lysine electrolyte deficient media) were the culture Medias used for this study.
On first day the inoculation for blood, HVS, sputum, stool and pus specimens, were done on Blood agar and Macconkey's agar. While CLED agar was used for urine specimens. The bacteriuric strips were used to collect the urine specimens for inoculation on CLED agar. The plates were then incubated at 37 0 C for 24 hours. After wards, the remaining urine specimens were transferred in the test tubes for 05 minutes centrifugation at 3000rpm. The supernatant was removed and deposits were used for direct microscopy to detect the presence of pus cells.
The pyuria was than correlated with bacteriuria for further processing.
The second day proceedings include the diagnosis of significant colonies by gram staining and biochemical tests. The linezolid having 30µgm disc potency was used to detect the susceptibility pattern on Mueller Hinton agar on the same day.
On third day, biochemical tests and drug susceptibility were interpreted as per recommended CLSI guidelines, and the reports were finalized. As per CLSI guidelines the linezolid disc having the zone diameter of >21mm was considered sensitive.
While <21mm zone diameter was considered as resistant.
While for all blood cultures the processing was done uptil 07 th days.
SPSS Version was used for statistical inference. Frequencies and percentages were the numerical variables extracted by using the SPSS version 20.
Results
Total 748 (n) specimens received in microbiology section of the i.e 11.1 % (n=16), sputum i.e 6.2% (n=09), blood i.e 4.1% (n=6), and lastly the stool i.e 2.7% (n=04). This is shown in table 1. 
Discussions
The management of MRSA and VRSA always remained a challenging task for the health professionals around the globe.
Literature review had shown that the prevalence of MRSA associated nosocomial infection in China, Korea and Japan are 60%. In Europe, it is 45% and in United States, it is 35% The susceptibility pattern of linezolid extracted from current study will be helpful and a guide for initiating the prophylactic management decisions in various circumstances.
Conclusion
The linezolid sensitivity for gram-positive organisms is 84.2%.
While for gram-negative organisms, it is 45.6%. The efficacy of linezolid is more for gram positive as compared to gram negative.
Recommendations
Linezolid can be used for the management of severe infections by gram negative isolates.
The studies with larger sample size are required to assess the efficacy of linezolid for gram negative organisms. 
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